Biotechnology Blueprint Medicines Announces FDA Approval of GAVRETO(TM) (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer September 4, 2020
Biotechnology Alexion Pharmaceuticals (ALXN) Gains As Market Dips: What You Should Know September 4, 2020
Biotechnology BioMarin Pharmaceutical (BMRN) Gains As Market Dips: What You Should Know September 4, 2020
Biotechnology Bluebird (BLUE) Down 7.8% Since Last Earnings Report: Can It Rebound? September 4, 2020
Biotechnology Allogene Therapeutics (ALLO) Down 9.9% Since Last Earnings Report: Can It Rebound? September 4, 2020